Federal Service for Surveillance in Healthcare reports information about the detection of the drug “AMIODARON, concentrate for preparation of solution for intravenous injection 50 mg/ml 3 ml, ampoules (10), packs of cartons, series 080519 manufactured by Ellara LLC (Russia), which quality does not meet the requirements of the regulatory documentation for the indicator “related impurities”
